EP3962455
Ný lyfjasamsetning til dreifingar á lyfi
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
18.5.2021EP published:
31.8.2022EP application number:
21728101.3
EP translation filed:
10.10.2022Grant published:
15.11.2022EPO information:
European Patent Register
Max expiry date:
17.5.2041Expiry date:
17.5.2026Next due date:
31.5.2026
Title in English:
NEW PHARMACEUTICAL COMPOSITION FOR DRUG DELIVERYLanguage of the patent:
English
Timeline
Today
18.5.2021EP application
31.8.2022EP Publication
10.10.2022Translation submitted
15.11.2022Registration published
17.5.2026Expires
Owner
Name:
Orexo ABAddress:
Box 303, 751 05 Uppsala, SE
Inventor
Name:
SÄVMARKER, JonasAddress:
751 05 Uppsala, SE
Name:
RÖNN, RobertAddress:
751 05 Uppsala, SE
Name:
FISCHER, AndreasAddress:
751 05 Uppsala, SE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
202007306Date:
18.5.2020Country:
GB
Number:
202009905Date:
29.6.2020Country:
GB
Number:
202018901Date:
1.12.2020Country:
GB
Classification
Categories:
A61K 9/00, A61K 9/16, A61K 31/00, A61K 38/095, A61P 13/00, A61K 38/00
Annual fees
Number
Paid
Expires
Payer
Number: 3
Paid: 24.5.2023
Expires: 17.5.2024
Payer: Árnason Faktor ehf.
Number: 4
Paid: 24.5.2024
Expires: 17.5.2025
Payer: Árnason Faktor ehf.
Number: 5
Paid: 23.5.2025
Expires: 17.5.2026
Payer: Árnason Faktor ehf.